<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11860578</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1072</article-id><article-id pub-id-type="other">EPV0342</article-id><article-id pub-id-type="pii">S0924933824010721</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Depressive symptoms, insomnia and dyspnea in COVID-19 survivors: a tunisian study</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Nadia</surname><given-names>B.</given-names></name><xref rid="aff2430" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor0928" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Mariem</surname><given-names>T.</given-names></name><xref rid="aff2430" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Houda</surname><given-names>B. A.</given-names></name><xref rid="aff2431" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ghada</surname><given-names>C.</given-names></name><xref rid="aff2430" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Sahar</surname><given-names>E.</given-names></name><xref rid="aff2430" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Sameh</surname><given-names>M.</given-names></name><xref rid="aff2432" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Sami</surname><given-names>K.</given-names></name><xref rid="aff2432" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Najla</surname><given-names>H.</given-names></name><xref rid="aff2430" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Jihen</surname><given-names>A.</given-names></name><xref rid="aff2430" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff2430"><sup>1</sup>Psychiatry B</aff><aff id="aff2431"><sup>2</sup>Preventive medicine and hospital hygiene</aff><aff id="aff2432"><sup>3</sup>Pneumology, <institution>Hedi Chaker university Hospital</institution>, <city>Sfax</city>, <country>Tunisia</country></aff><author-notes><corresp id="cor0928"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1047">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S516</fpage><lpage>S516</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824010721a.pdf"/><abstract><sec id="sec5580"><title>Introduction</title><p>The coronavirus infection emerging in 2019 caused a plethora of physical and mental health problems around the world. Recent studies showed a persistent psychological distress even after few months of the infection.</p></sec><sec id="sec5581"><title>Objectives</title><p>To determine the prevalence of depressive symptoms, insomnia and dyspnea among covid-19 survivors.</p></sec><sec id="sec5582"><title>Methods</title><p>We conducted a prospective cohort study including 121 Tunisian COVID-19 inpatients&#x000a0;who had been discharged alive from hospital. Each enrolled patient was asked about the period before the hospital stay, and the 6-9 month-period after hospital discharge. Patient Health Questionnaire-9 (PHQ-9) was used to assess depressive symptoms. We assessed <italic toggle="yes">insomnia via the insomnia severity index (ISI) and dyspnea through the mMRC (</italic>modified British Medical Research Council<italic toggle="yes">).</italic></p></sec><sec id="sec5583"><title>Results</title><p>The median age of participants was 59 years. The prevalence of depressive symptoms and insomnia increased significantly after the pandemic (5.7% vs 57.9%, p=0.038, r=0.189; and 4.9% vs 26.4%; p&#x0003c;0.0001, r=0.349 respectively). Younger patients presented more depressive symptoms (p&#x0003c;0.0001). females were more likely to suffer from depressive symptoms (p&#x0003c;0.0001). Dyspnea was more prevalent among survivors with depressive symptoms (p=0.001). Patients with depressive symptoms exhibited more insomnia (p&#x0003c;0.0001).</p></sec><sec id="sec5584"><title>Conclusions</title><p>The pandemic of covid19 emerged a wide range of physical and mental health problems with complex physiopathology. The early detection of these disorders improves the quality of life of these patients.</p></sec><sec id="sec5585"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>